Pharmadelic Labs aims to develop a portfolio of intellectual property around biosynthesis pathways for creating compounds. This has great potential for application in the pharmaceuticals industry.
The company's patent portfolio will develop as follows:
File for provisional patent applications
Continue to update patents as technology develops
Strengthen existing patents with further applications around biosynthesis pathways as results are known
Here’s how the biosynthesis of psilocybin works:
Step 1
Order synthetic DNA from hallucinogenic mushrooms
Step 2
Install DNA into genome of industrial brewing yeast
Step 3
Cultivate yeast on a large scale
Step 4
Extract psilocybin
Step 5
Create pharmaceutical products
THE OPTIMAL PROCESS
Pharmadelic Labs’ biosynthesis process is clean and economical, and much quicker than cultivating mushrooms by themselves – 3 days rather than 10 weeks. It also ensures consistent levels of psilocybin and is safe due to yeast’s status as Generally Recognized As Safe (GRAS).
Pharmadelic Labs will also be providing an effective alternative to chemical synthesis. Chemical synthesis of psilocybin costs upwards of $7,000 per gram, which is far more expensive than our methods
RESEARCH
Peer-reviewed studies have already been published about the potential benefits of psychoactive substances (including psilocybin) for mental health. Examples of research can be found here.